                         SEQUENCE LISTING

<110>  INSERM
 
<120>  NEW ANTI-NRG1 ANTIBODIES AND USES THEREOF

<130>  13056LARBOURET/AS

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide ranging from amino acids 151-164 of human NRG1

<400>  1

Glu Ser Pro Ile Arg Ile Ser Val Ser Thr Glu Gly Ala Asn 
1               5                   10                  


<210>  2
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide ranging from amino acids 154-168 of human NRG1

<400>  2

Ile Arg Ile Ser Val 
1               5   


<210>  3
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 H-CDR1

<400>  3

Gly Tyr Ala Phe Thr Thr Tyr Leu 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 H-CDR2

<400>  4

Ile Asn Pro Glu Ile Gly Lys Thr 
1               5               


<210>  5
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 H-CDR3

<400>  5

Ala Arg Glu Gly Asp Tyr Gly Ser Ser His Phe Ala Tyr 
1               5                   10              


<210>  6
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 L-CDR1

<400>  6

Gln Ser Ile Val Tyr Ser Asn Gly Ile Thr Tyr 
1               5                   10      


<210>  7
<211>  3
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 L-CDR2

<400>  7

Lys Val Ser 
1           


<210>  8
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  7E3 L-CDR3

<400>  8

Phe Gln Gly Ser His Val Pro Leu Thr 
1               5                   


